title: Inhibition of IL-1beta transcription by peptides derived from the hCMV IE2 transactivator.
abstract: The immediate early (IE) proteins of human cytomegalovirus (hCMV) have diverse roles in directing viral and host cell transcription. Among these is the ability of IE2 to induce transcription of the IL1B gene that codes for IL-1beta in monocytes. This function is partially explained by interaction between IE2 and the host cell transcription factor Spi-1/PU.1 (Spi-1). We now show that maximal IE2 function also depends on productive interactions localizing to two C/EBP sites on the IL1B promoter suggesting either bi- or tri-molecular interactions between IE2, Spi-1 and C/EBPbeta at two different locations on the promoter. The IE2 interaction region on Spi-1 was previously mapped to the DNA-binding ETS domain and overlaps the region of Spi-1 that interacts with the transcription factor C/EBPbeta, a factor known to be critical for the induction of IL1B in response to Toll/IL-1 receptor (TIR) family signal transduction. The Spi-1 interacting region of IE2 maps to amino acids 315-328, a sequence that also interacts with the bZIP domain of C/EBPbeta. An expression vector coding for amino acids 291-364 of IE2 can suppress LPS induction of a co-transfected IL1B enhancer-promoter fragment in a monocyte cell line. This inhibition is likely the result of competition between Spi-1 and C/EBPbeta, thus blunting gene induction.
authors.affiliation: SUNY Upstate Medical University, Syracuse, NY 13210, USA. listmanj@upstate.edu
authors.forename: James A
authors.initials: JA
authors.lastname: Listman
authors.forename: JoAnne E
authors.initials: JE
authors.lastname: Race
authors.forename: Nancy
authors.initials: N
authors.lastname: Walker-Kopp
authors.forename: Sebnem
authors.initials: S
authors.lastname: Unlu
authors.forename: Philip E
authors.initials: PE
authors.lastname: Auron
mesh_terms: D022782:CCAAT-Enhancer-Binding Protein-beta / Q000737:chemistry / Q000378:metabolism; D002460:Cell Line; D003587:Cytomegalovirus / Q000276:immunology / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D017874:Immediate-Early Proteins / Q000737:chemistry / Q000378:metabolism*; D053583:Interleukin-1beta / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D010455:Peptides / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D011401:Promoter Regions, Genetic; D017434:Protein Structure, Tertiary; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000378:metabolism; D015534:Trans-Activators / Q000737:chemistry / Q000378:metabolism*; D014158:Transcription, Genetic; D014162:Transfection; D000099232:Proto-Oncogene Protein Spi-1
chemical_list: D022782:CCAAT-Enhancer-Binding Protein-beta; D017874:Immediate-Early Proteins; D053583:Interleukin-1beta; D010455:Peptides; D011518:Proto-Oncogene Proteins; D015534:Trans-Activators; D000099232:Proto-Oncogene Protein Spi-1; C069186:IE2 protein, Cytomegalovirus